Efficacy of Auricular Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: A Case Series of 73 Cases
- PMID: 35003493
- PMCID: PMC8729890
- DOI: 10.1089/acu.2020.1506
Efficacy of Auricular Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: A Case Series of 73 Cases
Abstract
Background: Chemotherapy-induced peripheral neuropathy (CIPN) can adversely affect completion of systemic anticancer treatment and cause long-term morbidity. To date, its physiopathology remains unclear, and treatments are rare and poorly performed. Auricular acupuncture has already offered interesting results in several symptoms. Objective: This study (AACIPN2020) assessed the efficacy of auriculotherapy in CIPN. Design: We used patients' systematically collected data of 2014-2016 in a medical oncology practice. The treatment was made according to guidelines of the interuniversity diploma and the cartography of the World Health Organization. Pain assessment according to the Common Terminology Criteria for Adverse Event scale was orally collected. Results: Seventy-three cancer patients were treated for CIPN. They had finished chemotherapy 24 weeks prior on average. They received on average 23 punctures at each appointment. Sixty-five percent of patients met satisfaction, with 31% with a real impact on their daily life. Efficacy appeared after one or two treatments for 96% of cases. Some patients continued treatment to maximize benefits. Conclusions: Auricular acupuncture is a safe and inexpensive method of CIPN treatment. It may be applied earlier in chemotherapy administration, and in a large variety of other symptoms. Clinical trial registration number: COS RGDS 2019 09 001.
Keywords: auricular acupuncture; auriculotherapy; cancer; chemotherapy-induced peripheral neuropathy; neuropathy.
Copyright 2021, Mary Ann Liebert, Inc., publishers.
Conflict of interest statement
No competing financial interests exist.
Figures

Similar articles
-
Efficiency of auricular acupuncture in climacteric symptoms after cancer treatments.Climacteric. 2016 Jun;19(3):274-8. doi: 10.3109/13697137.2016.1164135. Epub 2016 Apr 22. Climacteric. 2016. PMID: 27102586
-
Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial.Oncologist. 2021 Nov;26(11):e2070-e2078. doi: 10.1002/onco.13933. Epub 2021 Aug 26. Oncologist. 2021. PMID: 34390283 Free PMC article. Clinical Trial.
-
Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.Oncologist. 2020 Apr;25(4):310-318. doi: 10.1634/theoncologist.2019-0489. Epub 2019 Oct 14. Oncologist. 2020. PMID: 32297442 Free PMC article. Clinical Trial.
-
A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy.Curr Oncol. 2019 Apr;26(2):e147-e154. doi: 10.3747/co.26.4261. Epub 2019 Apr 1. Curr Oncol. 2019. PMID: 31043820 Free PMC article.
-
Evaluating Acupuncture for the Treatment of Chemotherapy-induced Peripheral Neuropathy: An Integrative Review.West J Nurs Res. 2022 Feb;44(2):169-179. doi: 10.1177/0193945921992538. Epub 2021 Feb 9. West J Nurs Res. 2022. PMID: 33559535 Review.
Cited by
-
Recent advances in the treatment and prevention of peripheral neuropathy after multiple myeloma treatment.Ibrain. 2023 Sep 6;9(4):421-430. doi: 10.1002/ibra.12132. eCollection 2023 Winter. Ibrain. 2023. PMID: 38680507 Free PMC article. Review.
References
-
- Seretny M, Currie GL, Sena ES, et al. . Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461–2470. - PubMed
-
- Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol. 2006;33(1):15–49. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous